# Ophthotech Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ophthotech

- Industry: Healthcare
- Headquarters: Princeton, US
- Website: www.ophthotech.com
- Total disclosed funding: $140M
- Latest round: Series C (May 29, 2013)
- Investors on record: 5

## About

Ophthotech Corp. is based in Princeton, US and is a privately held, clinical stage biotechnology company, which engages in developing and commercializing therapies for wet and dry age-related macular degeneration.

## Funding rounds

- Series C, May 29, 2013, $50M — HBM Partners, SV Health Investors, Novo Holdings, Clarus Ventures, Novo Holdings
- Series B, Dec 15, 2009, $30M — HBM Partners, SV Health Investors, Novo Holdings, Clarus Ventures
- Series A, Apr 16, 2008, $24M — HBM Partners, SV Health Investors, Novo Holdings, Biogen Idec New Ventures
- Series A, Aug 9, 2007, $36M — HBM Partners, SV Health Investors, Novo Holdings
- Seed, Jun 1, 2007 — SV Health Investors

## Investors

- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Seed, Series A, Series B, Series C
- HBM Partners (https://capitalatlas.ai/funds/hbm-partners) — Series A, Series B, Series C
- Novo Holdings — Series A, Series B, Series C
- Biogen Idec New Ventures (https://capitalatlas.ai/funds/biogen-idec-new-ventures) — Series A
- Clarus Ventures (https://capitalatlas.ai/funds/clarus-ventures) — Series B, Series C